The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125308732 12530873 2 F 20150625 20160721 20160706 20160727 EXP IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-053951 BRISTOL MYERS SQUIBB 56.66 YR M Y 65.00000 KG 20160727 CN IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125308732 12530873 1 PS DAKLINZA DACLATASVIR 1 Oral 60 MG, QD 1680 MG U 206843 60 MG FILM-COATED TABLET QD
125308732 12530873 2 SS REBETOL RIBAVIRIN 1 Oral 1000 MG, QD 28000 MG U 0 1000 MG CAPSULE QD
125308732 12530873 3 SS SOFOSBUVIR SOFOSBUVIR 1 Oral 400 MG, QD 11200 MG U 0 400 MG TABLET QD
125308732 12530873 4 C ESKIM OMEGA-3 FATTY ACIDS 1 Oral 3000 MG, UNK U 0 3000 MG CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125308732 12530873 1 Chronic hepatitis C
125308732 12530873 2 Chronic hepatitis C
125308732 12530873 3 Chronic hepatitis C
125308732 12530873 4 Hypertriglyceridaemia

Outcome of event

Event ID CASEID OUTC COD
125308732 12530873 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125308732 12530873 Hepatic lesion
125308732 12530873 Hepatic neoplasm
125308732 12530873 Hepatocellular carcinoma

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125308732 12530873 1 20150529 20151112 0
125308732 12530873 2 20150529 20151112 0
125308732 12530873 3 20150529 20151112 0
125308732 12530873 4 20140701 0